Почетна › Метастатски карцином › Северна Каролина
Kliničke studije za Метастатски карцином u državi Северна Каролина
52 studija za Метастатски карцином traži učesnike na lokacijama u državi Северна Каролина.
Gradovi u državi Северна Каролина
- Durham33 студија
- Charlotte12 студија
- Wilson4 студија
- Cary4 студија
- Winston-Salem4 студија
- Raleigh4 студија
Zvanični tekst studije (na engleskom)
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Carolina Cancer Research Center, Wilson
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06270706Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Cone Health MedCenter Asheboro, Asheboro
- Cone Health Cancer Center at Alamance Regional, Burlington
- Southeastern Medical Oncology Center-Clinton, Clinton
- и још 9
Тражи се учесникФаза 2
Сви узрасти · Оба пола · Ажурирано 12. 11. 2026. · NCT05564377Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)
- Duke University Medical Center, Durham
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT04886804LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
- WakeMed Health & Hospitals, Cary
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT06216301ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
- Duke Cancer Institute, Durham
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07007559Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- FirstHealth of the Carolinas, Pinehurst
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT07562152A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
- Duke University Medical Center, Durham
Тражи се учесникФаза 1/2
Узраст 12 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT05384626A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Messino Cancer Centers, Asheville
- WakeMed Cancer Care - Waverly Hematology & Medical Oncology, Cary
- University of North Carolina Medical Center, Chapel Hill
- и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07174336A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Duke Cancer Institute, Durham
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07213804A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- University of North Carolina Medical Center, Chapel Hill
- Duke Cancer Institute, Durham
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06119581FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- University of North Carolina (UNC) - Chapel Hill, Chapel Hill
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT05614739A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
- Levine Cancer Institute, Charlotte
Тражи се учесникФаза 1/2
Узраст 18 и старији · Жене · Ажурирано 3. 11. 2026. · NCT04802759Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
- Atrium Health Carolinas Medical Center, Charlotte
- Duke Health - Duke University Hospital, Durham
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT05856981Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- University of North Carolina at Chapel Hill, Chapel Hill
- Duke University Medical Center, Durham
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT06943755Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 or 2 Systemic Treatment Regimens
- Duke University, Durham
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT06127407A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Research Site, Durham
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06835569A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- Duke Cancer Center, Durham
Тражи се учесникФаза 1
Узраст 18 и старији · Мушкарци · Ажурирано 20. 10. 2026. · NCT07103018REMASTer: REcurrent Brain Metastases After SRS Trial
- Wake Forest Baptist Medical Center, Winston-Salem
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT05124912GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
- Carolina Biooncology Institute, Huntersville
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT04977453A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill
- Levine Cancer Institute, Charlotte
- University of North Carolina Hospitals at Hillsborough, Hillsborough
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT06989437Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- FirstHealth Cancer Center, Pinehurst
- FirstHealth Moore Regional Hospital, Pinehurst
- Carolina Cancer Research Center, Wilson
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07222566Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Duke Cancer Center Cary, Cary
- Duke Cancer Center - Investigational Chemotherapy Service, Durham
- Duke Cancer Center, Durham
- и још 2
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07222800A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Levine Cancer Institute, Charlotte
- Oncology Specialists of Charlotte, Charlotte
- Wake Forest Baptist Health, Winston-Salem
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT07218380FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Duke University, Durham
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT05919264BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
- Avenzo Therapeutics Recruiting Site, Chapel Hill
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 5. 10. 2026. · NCT07193511The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Duke University, Durham
Тражи се учесникФаза 1/2
Узраст 12 и старији · Оба пола · Ажурирано 2. 10. 2026. · NCT04585750A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Levine Children's Hospital- Pediatric Neuro-Oncology, Charlotte
Тражи се учесникФаза 1/2
До 25 година · Оба пола · Ажурирано 25. 9. 2026. · NCT04094610A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
- Atrium Health Levine Cancer Institute, Charlotte
Тражи се учесникФаза 1/2
Узраст 12 и старији · Оба пола · Ажурирано 24. 9. 2026. · NCT05118789Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Carolina Biooncology Institute, Huntersville
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 18. 9. 2026. · NCT05267626Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Regional Medical Oncology Center_Wlson, Wilson
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 2. 9. 2026. · NCT06072612Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Greenville
- Research Site, Pinehurst
Тражи се учесникФаза 3
Узраст 18 и старији · Жене · Ажурирано 29. 7. 2026. · NCT07044336Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
- Investigative Site #131, Raleigh
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 23. 7. 2026. · NCT06974110PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 14. 7. 2026. · NCT06896162A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors
- Exelixis Clinical Site #1, Hickory
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 24. 6. 2026. · NCT06952010Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
- W.G. Bill Hefner Medical Center, Salisbury
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 15. 6. 2026. · NCT05422911First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
- Research Site, Durham
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 12. 6. 2026. · NCT07284186Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- Duke Cancer Center, Durham
- Carolina BioOncology Institute, Huntersville
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 3. 6. 2026. · NCT06040541Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
- Carolina BioOncology Institute, Huntersville
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 19. 5. 2026. · NCT05431270UNC Childhood, Adolescent, and Young Adult Cancer Cohort
- University of North Carolina at Chapel Hill, Chapel Hill
Тражи се учесникОпсервациона студија
Узраст од 1 до 39 · Оба пола · Ажурирано 12. 5. 2026. · NCT05096923UNC Metastatic Cancer Radiation Therapy Registry
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 6. 5. 2026. · NCT06306924Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.